After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. The stock was recently discussed on Yahoo Finance as it revealed that BioLife Solutions to Present at TD Cowen and Key Bank Investor Conferences.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
BLFS belongs to the Healthcare sector of the NASDAQ while operating in the Medical Instruments & Supplies industry. The current market capitalization of Biolife Solutions Inc is $793.66M. A total of 0.68 million shares were traded on the day, compared to an average of 422.16K shares.
In the most recent transaction, Phillips Geraint sold 131 shares of BLFS for 17.35 per share on Feb 21 ’24. After the transaction, the SVP, Global Operations now owns 58,120 company shares. In a previous transaction on Feb 21 ’24, Berard Todd sold 111 shares at 17.35 per share. BLFS shares that Chief Marketing Officer owns now total 115,688.
Among the insiders who sold shares, Mathew Aby J. disposed of 101 shares on Feb 21 ’24 at a per-share price of $17.35. This resulted in the EVP & Chief Scientific Officer holding 275,214 shares of BLFS after the transaction. In another insider transaction, Wichterman Troy sold 97 shares at $17.35 per share on Feb 21 ’24. Company shares held by the Chief Financial Officer now total 64,823.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, BLFS has a high of $24.50 and a low of $8.92.
As of this writing, BLFS has an earnings estimate of -$0.31 per share for the current quarter. EPS was calculated based on a consensus of 6 estimates, with a high estimate of -$0.13 per share and a lower estimate of -$0.41. The company reported an EPS of -$0.67 in the last quarter, which was -81.10% lower than expectations of -$0.37.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. BLFS’s latest balance sheet shows that the firm has $69.86M in Cash & Short Term Investments as of fiscal 2021. There were $26.88M in debt and $42.70M in liabilities at the time. Its Book Value Per Share was $7.48, while its Total Shareholder’s Equity was $478.05M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BLFS is Buy with a score of 4.75.
